Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hafnia alvei HA4597
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Inoliva
Deal Size : Undisclosed
Deal Type : Partnership
Details : Satylia, also called EnteroSatys in other markets, is a precision probiotic with a characterized mechanism of action at molecular level: it increases feelings of fullness thanks to the probiotic's protein ClpB that mimics the satiety hormone alpha-MSH.
Product Name : Satylia
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 27, 2022
Lead Product(s) : Hafnia alvei HA4597
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Inoliva
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Probiosatys
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate Benefit of ProbioSatysâ„¢ on Weight Reduction in Overweight Subjects
Details : Probiosatys is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Overweight.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 04, 2018
Lead Product(s) : Probiosatys
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
